ANOGX | NRGSX | ANOGX / NRGSX | |
Total Expense Ratio | 0.94 | 0.74 | 127% |
Annual Report Gross Expense Ratio | 0.94 | 0.74 | 127% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 6.208 | -3.458 | -180% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.8B | 8.8B | 55% |
Annual Yield % from dividends | 0.28 | 0.06 | 433% |
Returns for 1 year | 8.29 | -7.18 | -115% |
Returns for 3 years | 46.28 | 9.33 | 496% |
Returns for 5 years | -0.46 | -1.44 | 32% |
Returns for 10 years | N/A | 10.14 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AFMBX | 39.09 | 0.17 | +0.44% |
American Funds American Balanced F3 | |||
CECYX | 30.38 | N/A | N/A |
Columbia Large Cap Enhanced Core Inst3 | |||
GMCUX | 16.99 | N/A | N/A |
Goldman Sachs Small/Mid Cap Equity R6 | |||
PRIAX | 35.03 | N/A | N/A |
Principal Glb Emerging Markets A | |||
CVMAX | 22.22 | N/A | N/A |
Calvert Emerging Markets Equity A |